SynthesisCanadian family physician Medecin de famille canadien2014
Guideline for referral of patients with suspected lung cancer by family physicians and other primary care providers.
Synthesis in Canadian family physician Medecin de famille canadien, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.
- Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines.Frontiers in neurology · 2020Pooled it
- Systematic review of guidelines for the management of suspected lung cancer in primary care.Canadian family physician Medecin de famille canadien · 2014Pooled it
- Closing the gap - lung cancer evaluation and treatment among indigenous and non-indigenous patients in the Top End, Northern Territory, Australia.Internal medicine journal · 2026Article
- Missed Incidental Lung Cancer on Neck CT: Determinants and Impact on Diagnostic Delay and Stage Shift.Korean journal of radiology · 2026Article
- The Value of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Central Lung Cancer with Obstructive Atelectasis.Diagnostics (Basel, Switzerland) · 2024Article
- Death by a thousand delays.JTCVS open · 2024Article
- Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations.Clinics and practice · 2021Review
- Wait times in the management of non-small cell lung carcinoma before, during and after regionalization of lung cancer care: a high-resolution analysis.Canadian journal of surgery. Journal canadien de chirurgie · 2021Article
- Observational
- Lung Cancer Pre-Diagnostic Pathways from First Presentation to Specialist Referral.Current oncology (Toronto, Ont.) · 2021Article
- Rapid recommendations: Updates from 2019 guidelines: part 1.Canadian family physician Medecin de famille canadien · 2020Article
- Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors.World journal of gastrointestinal oncology · 2019Article
- Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011.Current oncology (Toronto, Ont.) · 2017Article
- Wait times for diagnosis and treatment of lung cancer: a single-centre experience.Current oncology (Toronto, Ont.) · 2017Article
- Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.The Annals of thoracic surgery · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this guideline is to assist FPs and other primary care providers with recognizing features that should raise their suspicions about the presence of lung cancer in their patients. COMPOSITION OF THE COMMITTEE: Committee members were selected from among the regional primary care leads from the Cancer Care Ontario Provincial Primary Care and Cancer Network and from among the members of the Cancer Care Ontario Lung Cancer Disease Site Group.
methodsThis guideline was developed through systematic review of the evidence base, synthesis of the evidence, and formal external review involving Canadian stakeholders to validate the relevance of recommendations. REPORT: Evidence-based guidelines were developed to improve the management of patients presenting with clinical features of lung cancer within the Canadian context.
conclusionEarlier identification and referral of patients with lung cancer might ultimately help improve lung cancer morbidity and mortality. These guidelines might also be of value for informing the development of lung cancer diagnostic programs and for helping policy makers to ensure appropriate resources are in place.
Indexed as
Identifiers
25122814PMC4131959W2118701349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.